Addressing the Impact of Type 2 Diabetes on AVF Maturation and Postoperative Hemodynamics
Overview
Overview
Authors
Authors
Affiliations
Affiliations
Soon will be listed here.
References
1.
Vassalotti J, Jennings W, Beathard G, Neumann M, Caponi S, Fox C
. Fistula first breakthrough initiative: targeting catheter last in fistula first. Semin Dial. 2012; 25(3):303-10.
DOI: 10.1111/j.1525-139X.2012.01069.x.
View
2.
Woodside K, Bell S, Mukhopadhyay P, Repeck K, Robinson I, Eckard A
. Arteriovenous Fistula Maturation in Prevalent Hemodialysis Patients in the United States: A National Study. Am J Kidney Dis. 2018; 71(6):793-801.
PMC: 6551206.
DOI: 10.1053/j.ajkd.2017.11.020.
View
3.
Wang Q, Zhang X, Zhu Q, Zeng H, Dai J, Chen J
. Application of extended immunotherapy in advanced clear cell renal cell carcinoma treated with first-line combination of immune-checkpoint inhibitor and tyrosine kinase inhibitor. Int Urol Nephrol. 2024; .
DOI: 10.1007/s11255-024-04344-7.
View
4.
Yan Y, Ye D, Yang L, Ye W, Zhan D, Zhang L
. A meta-analysis of the association between diabetic patients and AVF failure in dialysis. Ren Fail. 2018; 40(1):379-383.
PMC: 6014481.
DOI: 10.1080/0886022X.2018.1456464.
View
5.
Chen W, Feng Y, Yu M, Zhang Z, Wu J, Liu W
. Effects of different rehabilitation modality on cardiopulmonary function in patients with acute coronary syndrome after revascularization. Front Cardiovasc Med. 2024; 10:1120665.
PMC: 10945546.
DOI: 10.3389/fcvm.2023.1120665.
View